Yanai K, Yagi N, Watanabe T, Itoh M, Ishiwata K, Ido T, Matsuzawa T
Department of Pharmacology I, School of Medicine, Tohoku University, Sendai, Japan.
J Neurochem. 1990 Aug;55(2):409-20. doi: 10.1111/j.1471-4159.1990.tb04152.x.
The binding of [3H]pyrilamine, a selective ligand of histamine H1 receptors, to guinea pig brain in vivo was compared with its binding to a brain homogenate. The pharmacological properties (regional distribution, saturability, and stereoselectivity) of the [3H]pyrilamine binding in vivo were similar to those of the in vitro binding to brain homogenate. A dynamic four-compartment model was proposed for the analysis of the kinetics of [3H]pyrilamine binding in vivo. The receptor constants in vivo were determined by a computer-fitting method after correcting the radioactivity of arterial plasma and brain for the presence of radioactive metabolites. The in vivo association and dissociation were 213 and 42 times, respectively, slower than those of in vitro binding at 37 degrees C. A possible mechanism for slow association and dissociation in vivo is discussed.
将组胺H1受体的选择性配体[3H]吡苄明在豚鼠脑内的体内结合与其在脑匀浆中的结合进行了比较。[3H]吡苄明体内结合的药理学特性(区域分布、饱和性和立体选择性)与体外与脑匀浆结合的特性相似。提出了一个动态四室模型用于分析[3H]吡苄明体内结合的动力学。在校正动脉血浆和脑中放射性代谢物的存在后,通过计算机拟合方法确定体内受体常数。在37℃时,体内的结合和解离分别比体外结合慢213倍和42倍。讨论了体内结合和解离缓慢的可能机制。